A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy-Reference-Cited by-同舟云学术

A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

Published:2011-03 Issue:3 Volume:12 Page:211-214
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Galsky Matthew D,Hahn Noah M,Rosenberg Jonathan,Sonpavde Guru,Hutson Thomas,Oh William K,Dreicer Robert,Vogelzang Nicholas,Sternberg Cora,Bajorin Dean F,Bellmunt Joaquim

Publisher

Elsevier BV

Subject

Oncology

Reference8 articles.

1. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000

2. Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder;Dash;Cancer,2006

3. Chemotherapeutic options for cisplatin-ineligible patients with advanced carcinoma of the urothelium;Vaughn;Cancer Treat Rev,2008

4. Overview of bladder cancer trials in the European Organization for Research and Treatment;de Wit;Cancer,2003

5. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy;Bajorin;J Clin Oncol,1999

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer;Journal of Clinical Oncology;2024-09-06

2. Potential role of transmembrane 9 superfamily member 1 as a biomarker in urothelial cancer;World Journal of Clinical Oncology;2024-08-24

3. Reevaluating the role of platinum-based chemotherapy in the evolving treatment landscape for patients with advanced urothelial carcinoma;The Oncologist;2024-08-21

4. A Podcast on Practical Considerations in Patients with Advanced Urothelial Cancer Receiving First-Line Cisplatin- or Carboplatin-Based Chemotherapy Followed by Avelumab Maintenance in a Changing Therapeutic Landscape;Advances in Therapy;2024-07-18

5. Recent Advances of Neoadjuvant Immunotherapy for Urothelial Bladder Cancer;Annals of Surgical Oncology;2024-07-12